Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Gastrin/cholecystokinin type B receptor | ||
Ligand | BDBM50063657 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_48248 (CHEMBL661838) | ||
IC50 | 73±n/a nM | ||
Citation | Padia, JK; Field, M; Hinton, J; Meecham, K; Pablo, J; Pinnock, R; Roth, BD; Singh, L; Suman-Chauhan, N; Trivedi, BK; Webdale, L Novel nonpeptide CCK-B antagonists: design and development of quinazolinone derivatives as potent, selective, and orally active CCK-B antagonists. J Med Chem41:1042-9 (1998) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Gastrin/cholecystokinin type B receptor | |||
Name: | Gastrin/cholecystokinin type B receptor | ||
Synonyms: | Cckbr | Cholecystokinin A | Cholecystokinin receptor | GASR_MOUSE | Gastrin/cholecystokinin type B receptor | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 49196.59 | ||
Organism: | MOUSE | ||
Description: | Cholecystokinin A CCKBR MOUSE::P56481 | ||
Residue: | 453 | ||
Sequence: |
| ||
BDBM50063657 | |||
n/a | |||
Name | BDBM50063657 | ||
Synonyms: | CHEMBL9287 | N-(3-methylphenyl)-2-[3,4-dihydro-3-[(2,3-dichloro)phenyl]-4-oxo-2-quinazolinyl]hydrazinecarboxamide | ||
Type | Small organic molecule | ||
Emp. Form. | C22H17Cl2N5O2 | ||
Mol. Mass. | 454.309 | ||
SMILES | Cc1cccc(NC(=O)NNc2nc3ccccc3c(=O)n2-c2cccc(Cl)c2Cl)c1 |(17.57,-3.82,;16.23,-3.04,;16.26,-1.5,;14.93,-.71,;13.59,-1.47,;13.59,-3.02,;12.24,-3.79,;10.9,-3,;10.93,-1.46,;9.57,-3.76,;8.24,-2.99,;6.91,-3.75,;5.57,-2.97,;4.24,-3.74,;2.91,-2.97,;1.57,-3.74,;1.57,-5.28,;2.91,-6.06,;4.22,-5.28,;5.55,-6.06,;5.55,-7.6,;6.91,-5.29,;8.21,-6.08,;9.55,-5.31,;10.88,-6.09,;10.88,-7.63,;9.52,-8.39,;9.52,-9.94,;8.21,-7.61,;6.86,-8.37,;14.9,-3.8,)| | ||
Structure |